Editorial: Heterotopic ossification

References

• Ahrengardt L, Lindgren U. Heterotopic bone. Defining the patient at risk. Clin Orthop 1993; 293: 153–9
   Google Scholar
• Ayers D C, McCollister Evarts C, Parkinson J R. The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip replacement. J Bone Joint Surg (Am) 1978; 68: 1423–30
   Google Scholar
• Bjurholm A, Kreicbergs A, Schultzberg M, Lerner U. Parathyroid hormone and noradrenaline-induced enhancement of cyclic AMP in a cloned osteogenic cell line is inhibited by neuropeptide Y. Acta Physiol Scand 1988; 134: 451–2
   PubMedGoogle Scholar
• Coventry M B, Scanlon P W. The use of radiation to discourage ectopic bone. J Bone Joint Surg (Am) 1981; 63: 201–8
   PubMed Web of Science ®Google Scholar
• De Lee J, Ferrari A, Charnley J. Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop 1976; 121: 53–9
   Google Scholar
• Fingeroth R J, Ahmed A Q. Single-dose 6 Gy prophylaxis for heterotopic ossification after total hip arthroplasty. Clin Orthop 1995; 317: 131–40
   Google Scholar
• Gebuhr P, Sletgard J, Dalsgard J, Soelberg M, Keisu K, Han-Ninen A, Crawford M. Heterotopic ossification after hip arthroplasty. A randomized double-blind multicenter study of tenoxicam in 147 hips. Acta Orthop Scand 1996; 67: 29–32
   PubMed Web of Science ®Google Scholar
• Jowsey J, Coventry M B, Robins P R. Heterotopic ossification: Theoretical considerations, possible etiologic factors, and a clinical review of total hip arthroplasty patients exhibiting this phenomenon. In: The proceedings of the hip society. C.V. Mosby, 1977; 210–21
   Google Scholar
• Keller J C, Trancik T M, Young F A, St Mary E. Effects of indomethacin on bone ingrowth. J Orthop Res 1989; 7: 28–32
   PubMed Web of Science ®Google Scholar
• Kjaersgaard-Andersen P, Schmidt S A, Pedersen N W, Kristensen S S, Pedersen P. Early radiolucencies following cemented total hip replacement. Orthopaedics 1989; 12: 401–6
   PubMed Web of Science ®Google Scholar
• Knelles D, Barthel T, Karrer A, Kraus U, Eulert J, Kolbl O. Prevention of heterotopic ossification after total hip replacement. J Bone Joint Surg (Br) 1997; 79: 596–602
   PubMedGoogle Scholar
• Mital M A, Garber J E, Stinson J T. Ectopic bone formation in children. J Pediatr Orthop 1987; 7: 83–90
   PubMed Web of Science ®Google Scholar
• Nollen A J G. Effects of ethyldihydroxydiphosphonate (EHDP) on heterotopic ossification. Acta Orthop Scand 1986; 57: 358–61
   PubMed Web of Science ®Google Scholar
• Nollen J G, van Douveren F Q. Ectopic ossification in hip arthroplasty. A retrospective study of predisposing factors in 637 cases. Acta Orthop Scand 1993; 64: 185–7
   PubMed Web of Science ®Google Scholar
• Pellegrini V D, Gregoritch S J. Preoperative radiation for prevention of heterotopic ossification following total hip arthroplasty. J Bone Joint Surg (Am) 1996; 78: 870–81
   PubMed Web of Science ®Google Scholar
• Pritchett J W. Ketorolac prophylaxis against heterotopic ossification after hip replacement. Clin Orthop 1995; 314: 162–5
   Google Scholar
• Puzas J E, Rosier R N, Felter M E. Human heterotopic bone formation is associated with very high levels of spinal bone density. J Bone Mineral Res 1989a; 4: 976
   Google Scholar
• Puzas J E, Miller M D, Rosier R N. Pathologic bone formation. Clin Orthop 1989b; 245: 269–81
   Google Scholar
• Ritter M A, Sieber J N. Prophylactic indomethacin for the prevention of of heterotopic bone formation following total hip arthroplasty. Clin Orthop 1985; 196: 217–25
   Google Scholar
• Ritter M A, Vaughan R B. Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency and effects on results. J Bone Joint Surg (Am) 1977; 59: 345–51
   PubMed Web of Science ®Google Scholar
• Schmidt S A, Kjaersgaard-Andersen P, Pedersen N W, Kristensen S S, Pedersen P, Nielsen J B. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. J Bone Joint Surg (Am) 1988; 70: 834–8
   PubMed Web of Science ®Google Scholar
• Sodemann B, Persson P-E, Nilsson O S. Periarticular heterotopic ossification after total hip arthroplasty for primary coxarthrosis. Clin Orthop 1988; 237: 150–7
   Google Scholar
• Sodemann B, Persson P-E, Nilsson O S. Nonsteroid anti-inflammatory drugs prevent the recurrence of heterotopic bone after excision. Arch Orthop Trauma Surg 1990; 109: 53–6
   PubMed Web of Science ®Google Scholar
• Sudman E, Bang G. Indomethacin-induced inhibition of haversian remodeling in rabbits. Acta Orthop Scand 1979; 50: 621–7
   PubMedGoogle Scholar
• Sumner D R, Turner T M, Pierson R H, Kienapfel H, Urban R M, Liebner E J, Galante J O. Effects of radiation on fixation of noncemented porous-coated implants in a canine model. J Bone Joint Surg (Am) 1990; 72: 1527–33
   PubMedGoogle Scholar
• Thomas B J, Amstutz H C. Results of administration of diphosphonate for prevention of heterotopic ossification after total hip arthroplasty. J Bone joint Surg (Am) 1985; 67: 400–3
   PubMed Web of Science ®Google Scholar
• Törnkvist H, Bauer H C F, Nilsson O S. Influence of indomethacin on experimental bone metabolism in rats. Clin Orthop 1985; 193: 264–70
   PubMed Web of Science ®Google Scholar
• Wahlström O, Risto O, Djerf K, Hammerby S. Heterotopic bone formation prevented by diclofenac. Prospective study of 100 hip arthroplasties. Acta Orthop Scand 1991; 62: 419–521
   PubMed Web of Science ®Google Scholar
• Wurnig C, Auersperg V, Boehler N, Steindl M, Kiss H, ZweymuUer K, Kotz R. Short-term prophylaxis against heterotopic bone after cementless hip replacement. Clin Orthop 1977; 334: 175–83
   Google Scholar